loading

Policy and technical topics:Antimicrobial resistance - SEA/RC68/11 / World Health Organization. Regional Office for South-East Asia

Tác giả : World Health Organization. Regional Office for South-East Asia

Nhà xuất bản : WHO Regional Office for South-East Asia

Năm xuất bản : 2015

Chủ đề : 1. Governing body documents.

Thông tin chi tiết

Tóm tắt :

Antimicrobial resistance (AMR) is recognized as one of the principal threats to public health throughout the world. A regional strategy for prevention and containment of AMR was developed by the WHO Regional Office for South-East Asia in 2010. The strategy was endorsed by the Sixty-third Session of the Regional Committee through resolution SEA/RC63/R4 in 2010. AMR was the theme of World Health Day in 2011 to enhance global advocacy on the subject. Health ministers of countries of the South-East Asia Region deliberated upon this subject and adopted the “Jaipur Declaration on Antimicrobial Resistance” in 2011. AMR is a flagship priority identified by the Regional Director.In the last five years, the South-East Asia Region has made substantial progress in this area using the regional strategy as a guidance document, but more work is needed. The Sixty-seventh World Health Assembly, through resolution WHA67.25, requested WHO to develop a draft global action plan (GAP) to combat AMR which was endorsed at the Sixty-eighth World Health Assembly in 2015. GAP is in line with the regional strategy and the Jaipur Declaration and Member States are requested to prepare their national action plans in accordance with GAP in the next two years. The High-Level Preparatory (HLP) Meeting held in the WHO Regional Office in New Delhi from 29 June to 2 July 2015 reviewed the attached working paper and made the following recommendations.Actions by Member States•Draft a national action plan for AMR as urged in resolution WHA68.7 on Global action plan on AMR.•Implement and monitor progress in line with GAP and adapted to national priorities.Actions by WHO•Provide technical support to Member States in drafting and implementing national action plans.•Draft indicators for the Member States to help them in monitoring and evaluation of progress made in the development and implementation of national action plans.•Provide technical support to build capacity for laboratory-based surveillance and forge regional laboratory networks to understand the magnitude and trend of resistance, prepare standard treatment guidelines, and analyse impact of national interventions.•Advocate for development and enforcement of regulations for therapeutic and non-therapeutic use of antibiotics in human, veterinary and other relevant sectors.The working paper and the HLP recommendations are submitted to the Sixty-eighth Session of the Regional Committee for its consideration.

 Thông tin dữ liệu nguồn

 Thư viện  Ký hiệu xếp giá  Dữ liệu nguồn
Tổ chức y tế thế giới
https://iris.who.int/handle/10665/180789